{"url_path":"/sec/apyx/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **         **Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/719135/0001437749-26-016885-index.html","accession_number":"0001437749-26-016885","cik":"0000719135","ticker":"APYX","issuer_name":"Apyx Medical Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/719135/0001437749-26-016885-index.html","primary_entity_key":"0000719135","primary_entity_name":"Apyx Medical Corp"},"word_count":80,"has_tables":true,"body_markdown":"**Item 9.01**         **Financial Statements and Exhibits**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n\n**Description**\n\n \n\n99.1\n\n[Press release dated May 14, 2026](ex_962572.htm)\n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: May 14, 2026\n\n**Apyx Medical Corporation**\n\n \n\n \n \n \n \n\n \n\nBy:\n\n*/s/ Matthew Hill*\n\n \n\n \n \n\nMatthew Hill\n\n \n\n \n \n\nChief Financial Officer, Secretary and Treasurer"}